Paycom Software, Inc. Reports Third Quarter 2024 Results
Third Quarter Revenues of
Third Quarter GAAP Net Income of
Third Quarter Non-GAAP Net Income of
Third Quarter Adjusted EBITDA of
“We posted solid third quarter results and continue to make significant progress toward full-solution automation,” said Paycom founder, CEO and chairman,
Financial Highlights for the Third Quarter of 2024
Total Revenues of
GAAP Net Income was
Non-GAAP Net Income1was
Adjusted EBITDA1 was
Cash and Cash Equivalents were
Total Debt was
1 Adjusted EBITDA, non-GAAP net income and non-GAAP net income per diluted share are non-GAAP financial measures. Please see the discussion below under the heading “Use of Non-GAAP Financial Information” and the reconciliations at the end of this release for additional information concerning these and other non-GAAP financial measures.
Financial Outlook
Paycom provides the following expected financial guidance for the quarter and the year ending
Quarter Ending
Total Revenues in the range of
Adjusted EBITDA in the range of
Year Ending
Total Revenues in the range of
Adjusted EBITDA in the range of
We have not reconciled the forward-looking adjusted EBITDA ranges presented above and discussed on the teleconference call to net income, nor the forward-looking adjusted EBITDA margins and forward-looking non-GAAP effective income tax rate discussed on the teleconference call to comparable GAAP measures, because applicable information for future periods, on which these reconciliations would be based, is not readily available due to uncertainty regarding, and the potential variability of, depreciation and amortization, interest expense, taxes, non-cash stock-based compensation expense and other items. Accordingly, reconciliations of the forward-looking adjusted EBITDA ranges to net income, the forward-looking adjusted EBITDA margins to net income margin, and the forward-looking non-GAAP effective income tax rate to the GAAP effective income tax rate are not available at this time without unreasonable effort.
Use of Non-GAAP Financial Information
To supplement our financial information presented in accordance with generally accepted accounting principles in
The non-GAAP financial measures presented in this press release and discussed on the related teleconference call are not measures of financial performance under GAAP and should not be considered a substitute for net income, gross profit, gross margin, research and development expenses, sales and marketing expenses, administrative expenses, total research and development costs and GAAP effective income tax rate. Non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation, or as a substitute for the consolidated statements of income data prepared in accordance with GAAP. The non-GAAP financial measures that we present may not be comparable to similarly titled measures of other companies, and other companies may not calculate such measures in the same manner as we do.
Conference Call Details
In conjunction with this announcement, Paycom will host a conference call today,
About Paycom
For 25 years,
Forward-Looking Statements
Certain statements in this press release are, and certain statements on the related teleconference call may be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are any statements that refer to Paycom’s estimated or anticipated results, other non-historical facts or future events and include, but are not limited to, statements regarding our business strategy; anticipated future operating results and operating expenses, cash flows, capital resources, dividends and liquidity; competition; trends, opportunities and risks affecting our business, industry and financial results; future expansion or growth plans and potential for future growth, including internationally; our ability to attract new clients to purchase our solution; our ability to retain clients and induce them to purchase additional applications; our ability to accurately forecast future revenues and appropriately plan our expenses; market acceptance of our solution and applications; our expectations regarding future revenues generated by certain applications; the return on investment for users of our solution; our ability to attract and retain qualified employees and key personnel; future regulatory, judicial and legislative changes; how certain factors affecting our performance correlate to improvement or deterioration in the labor market; our plan to open additional sales offices and our ability to effectively execute such plan; the sufficiency of our existing cash and cash equivalents to meet our working capital and capital expenditure needs over the next 12 months; our plans regarding our capital expenditures and investment activity as our business grows, including with respect to research and development and the expansion of our facilities; our plans to pay cash dividends; our plans to repurchase shares of our common stock through a stock repurchase plan; and our expected income tax rate for future periods. In addition, forward-looking statements also consist of statements involving trend analyses and statements including such words as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “should,” “will,” “would,” and similar expressions or the negative of such terms or other comparable terminology. These forward-looking statements are based only on information currently available to us, speak only as of the date hereof and are subject to business and economic risks. As such, our actual results could differ materially from those set forth in the forward-looking statements as a result of the factors discussed in our filings with the
Unaudited Consolidated Balance Sheets (in thousands, except per share amounts)
|
||||||||
|
|
|
|
|
|
|
||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
325,757 |
|
|
$ |
294,025 |
|
Accounts receivable |
|
|
20,576 |
|
|
|
16,442 |
|
Prepaid expenses |
|
|
45,979 |
|
|
|
37,613 |
|
Inventory |
|
|
1,331 |
|
|
|
1,383 |
|
Income tax receivable |
|
|
10,341 |
|
|
|
18,391 |
|
Deferred contract costs |
|
|
134,270 |
|
|
|
118,206 |
|
Current assets before funds held for clients |
|
|
538,254 |
|
|
|
486,060 |
|
Funds held for clients |
|
|
1,439,651 |
|
|
|
2,327,366 |
|
Total current assets |
|
|
1,977,905 |
|
|
|
2,813,426 |
|
Property and equipment, net |
|
|
553,597 |
|
|
|
498,197 |
|
Intangible assets, net |
|
|
47,183 |
|
|
|
50,112 |
|
|
|
|
51,889 |
|
|
|
51,889 |
|
Long-term deferred contract costs |
|
|
753,290 |
|
|
|
680,272 |
|
Operating lease right-of-use assets |
|
|
77,958 |
|
|
|
73,762 |
|
Other assets |
|
|
30,708 |
|
|
|
29,881 |
|
Total assets |
|
$ |
3,492,530 |
|
|
$ |
4,197,539 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
35,044 |
|
|
$ |
13,875 |
|
Accrued commissions and bonuses |
|
|
23,377 |
|
|
|
30,492 |
|
Accrued payroll and vacation |
|
|
49,495 |
|
|
|
56,086 |
|
Deferred revenue |
|
|
28,885 |
|
|
|
22,812 |
|
Operating lease liabilities |
|
|
20,124 |
|
|
|
19,236 |
|
Accrued expenses and other current liabilities |
|
|
63,110 |
|
|
|
64,066 |
|
Current liabilities before client funds obligation |
|
|
220,035 |
|
|
|
206,567 |
|
Client funds obligation |
|
|
1,439,648 |
|
|
|
2,328,076 |
|
Total current liabilities |
|
|
1,659,683 |
|
|
|
2,534,643 |
|
Deferred income tax liabilities, net |
|
|
140,228 |
|
|
|
143,750 |
|
Long-term deferred revenue |
|
|
113,371 |
|
|
|
107,657 |
|
Long-term operating lease liabilities |
|
|
60,660 |
|
|
|
56,713 |
|
Other long-term liabilities |
|
|
53,936 |
|
|
|
51,740 |
|
Total long-term liabilities |
|
|
368,195 |
|
|
|
359,860 |
|
Total liabilities |
|
|
2,027,878 |
|
|
|
2,894,503 |
|
Commitments and contingencies |
|
|
|
|
|
|
||
Stockholders’ equity: |
|
|
|
|
|
|
||
Common stock, |
|
|
629 |
|
|
627 |
|
|
Additional paid-in capital |
|
|
697,892 |
|
|
|
724,493 |
|
Retained earnings |
|
|
1,795,476 |
|
|
|
1,469,981 |
|
Accumulated other comprehensive earnings (loss) |
|
|
(180 |
) |
|
|
(1,039 |
) |
|
|
|
(1,029,165 |
) |
|
|
(891,026 |
) |
Total stockholders’ equity |
|
|
1,464,652 |
|
|
|
1,303,036 |
|
Total liabilities and stockholders’ equity |
|
$ |
3,492,530 |
|
|
$ |
4,197,539 |
|
Unaudited Consolidated Statements of Comprehensive Income (in thousands, except per share amounts)
|
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Recurring |
|
$ |
445,002 |
|
|
$ |
398,763 |
|
|
$ |
1,367,298 |
|
|
$ |
1,237,706 |
|
Implementation and other |
|
|
6,932 |
|
|
|
7,540 |
|
|
|
22,029 |
|
|
|
21,373 |
|
Total revenues |
|
|
451,934 |
|
|
|
406,303 |
|
|
|
1,389,327 |
|
|
|
1,259,079 |
|
Cost of revenues |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Operating expenses |
|
|
70,818 |
|
|
|
55,600 |
|
|
|
201,939 |
|
|
|
163,302 |
|
Depreciation and amortization |
|
|
17,535 |
|
|
|
13,341 |
|
|
|
48,929 |
|
|
|
38,299 |
|
Total cost of revenues |
|
|
88,353 |
|
|
|
68,941 |
|
|
|
250,868 |
|
|
|
201,601 |
|
Administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sales and marketing |
|
|
104,477 |
|
|
|
101,162 |
|
|
|
326,865 |
|
|
|
311,171 |
|
Research and development |
|
|
63,047 |
|
|
|
51,864 |
|
|
|
175,927 |
|
|
|
143,651 |
|
General and administrative |
|
|
70,642 |
|
|
|
71,827 |
|
|
|
92,610 |
|
|
|
213,397 |
|
Depreciation and amortization |
|
|
20,541 |
|
|
|
15,608 |
|
|
|
57,229 |
|
|
|
44,660 |
|
Total administrative expenses |
|
|
258,707 |
|
|
|
240,461 |
|
|
|
652,631 |
|
|
|
712,879 |
|
Total operating expenses |
|
|
347,060 |
|
|
|
309,402 |
|
|
|
903,499 |
|
|
|
914,480 |
|
Operating income |
|
|
104,874 |
|
|
|
96,901 |
|
|
|
485,828 |
|
|
|
344,599 |
|
Interest expense |
|
|
(789 |
) |
|
|
(222 |
) |
|
|
(2,353 |
) |
|
|
(1,661 |
) |
Other income (expense), net |
|
|
4,229 |
|
|
|
5,362 |
|
|
|
14,025 |
|
|
|
17,549 |
|
Income before income taxes |
|
|
108,314 |
|
|
|
102,041 |
|
|
|
497,500 |
|
|
|
360,487 |
|
Provision for income taxes |
|
|
35,036 |
|
|
|
26,822 |
|
|
|
109,065 |
|
|
|
101,456 |
|
Net income |
|
$ |
73,278 |
|
|
$ |
75,219 |
|
|
$ |
388,435 |
|
|
$ |
259,031 |
|
Earnings per share, basic |
|
$ |
1.31 |
|
|
$ |
1.30 |
|
|
$ |
6.90 |
|
|
$ |
4.48 |
|
Earnings per share, diluted |
|
$ |
1.31 |
|
|
$ |
1.30 |
|
|
$ |
6.89 |
|
|
$ |
4.46 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
55,929 |
|
|
|
57,825 |
|
|
|
56,307 |
|
|
|
57,871 |
|
Diluted |
|
|
55,964 |
|
|
|
57,966 |
|
|
|
56,365 |
|
|
|
58,056 |
|
Comprehensive earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
73,278 |
|
|
$ |
75,219 |
|
|
$ |
388,435 |
|
|
$ |
259,031 |
|
Unrealized net gains on available-for-sale securities |
|
|
101 |
|
|
|
1,232 |
|
|
|
1,256 |
|
|
|
2,047 |
|
Tax effect |
|
|
24 |
|
|
|
(420 |
) |
|
|
(397 |
) |
|
|
(525 |
) |
Other comprehensive income, net of tax |
|
|
125 |
|
|
|
812 |
|
|
|
859 |
|
|
|
1,522 |
|
Comprehensive earnings: |
|
$ |
73,403 |
|
|
$ |
76,031 |
|
|
$ |
389,294 |
|
|
$ |
260,553 |
|
Unaudited Consolidated Statements of Cash Flows (in thousands)
|
||||||||
|
|
Nine Months Ended |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
||
Net income |
|
$ |
388,435 |
|
|
$ |
259,031 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
106,158 |
|
|
|
82,959 |
|
Accretion of discount on available-for-sale securities |
|
|
(112 |
) |
|
|
(387 |
) |
Non-cash marketing expense |
|
|
1,202 |
|
|
|
1,263 |
|
Gain on disposition of property and equipment |
|
|
(12 |
) |
|
|
(33 |
) |
Amortization of debt issuance costs |
|
|
831 |
|
|
|
946 |
|
Stock-based compensation expense |
|
|
(45,514 |
) |
|
|
96,383 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
1,222 |
|
Deferred income taxes, net |
|
|
(3,827 |
) |
|
|
3,889 |
|
Other |
|
|
(97 |
) |
|
|
18 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable |
|
|
(4,134 |
) |
|
|
7,295 |
|
Prepaid expenses |
|
|
(7,970 |
) |
|
|
(8,845 |
) |
Inventory |
|
|
869 |
|
|
|
375 |
|
Other assets |
|
|
(1,657 |
) |
|
|
(8,262 |
) |
Deferred contract costs |
|
|
(84,413 |
) |
|
|
(87,604 |
) |
Accounts payable |
|
|
13,088 |
|
|
|
(8,131 |
) |
Income taxes, net |
|
|
8,050 |
|
|
|
(5,187 |
) |
Accrued commissions and bonuses |
|
|
(7,115 |
) |
|
|
(8,016 |
) |
Accrued payroll and vacation |
|
|
(6,591 |
) |
|
|
(3,863 |
) |
Deferred revenue |
|
|
11,787 |
|
|
|
10,902 |
|
Net change in operating right-of-use assets and operating lease liabilities |
|
|
639 |
|
|
|
882 |
|
Accrued expenses and other current liabilities |
|
|
3,896 |
|
|
|
15,732 |
|
Net cash provided by operating activities |
|
|
373,513 |
|
|
|
350,569 |
|
Cash flows from investing activities |
|
|
|
|
|
|
||
Purchases of investments from funds held for clients |
|
|
(24,926 |
) |
|
|
(25,000 |
) |
Proceeds from investments from funds held for clients |
|
|
200,000 |
|
|
|
25,000 |
|
Purchases of property and equipment |
|
|
(141,549 |
) |
|
|
(135,709 |
) |
Proceeds from sale of property and equipment |
|
|
13 |
|
|
|
67 |
|
Net cash provided by (used in) investing activities |
|
|
33,538 |
|
|
|
(135,642 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
||
Repurchases of common stock |
|
|
(122,801 |
) |
|
|
(74,994 |
) |
Withholding taxes paid related to net share settlements |
|
|
(14,415 |
) |
|
|
(12,620 |
) |
Dividends paid |
|
|
(63,687 |
) |
|
|
(43,367 |
) |
Net change in client funds obligation |
|
|
(888,428 |
) |
|
|
(306,063 |
) |
Payment of debt issuance costs |
|
|
— |
|
|
|
(649 |
) |
Net cash used in financing activities |
|
|
(1,089,331 |
) |
|
|
(437,693 |
) |
Decrease in cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
(682,280 |
) |
|
|
(222,766 |
) |
Cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
|
|
|
|
||
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period |
|
|
2,422,760 |
|
|
|
2,409,095 |
|
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period |
|
$ |
1,740,480 |
|
|
$ |
2,186,329 |
|
Unaudited Consolidated Statements of Cash Flows, continued (in thousands)
|
||||||||
|
|
Nine Months Ended |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
325,757 |
|
|
$ |
484,028 |
|
Restricted cash included in funds held for clients |
|
|
1,414,723 |
|
|
|
1,702,301 |
|
Total cash, cash equivalents, restricted cash and restricted cash equivalents, end of period |
|
$ |
1,740,480 |
|
|
$ |
2,186,329 |
|
|
|
|
|
|
|
|
||
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
||
Non-cash investing and financing activities: |
|
|
|
|
|
|
||
Purchases of property and equipment, accrued but not paid |
|
$ |
3,640 |
|
|
$ |
8,011 |
|
Stock-based compensation for capitalized software |
|
$ |
13,850 |
|
|
$ |
11,529 |
|
Right of use assets obtained in exchange for operating lease liabilities |
|
$ |
17,507 |
|
|
$ |
21,023 |
|
Unaudited Reconciliations of GAAP to Non-GAAP Financial Measures (in thousands, except per share amounts)
|
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Net income to adjusted EBITDA: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
73,278 |
|
|
$ |
75,219 |
|
|
$ |
388,435 |
|
|
$ |
259,031 |
|
Interest expense |
|
|
789 |
|
|
|
222 |
|
|
|
2,353 |
|
|
|
1,661 |
|
Provision for income taxes |
|
|
35,036 |
|
|
|
26,822 |
|
|
|
109,065 |
|
|
|
101,456 |
|
Depreciation and amortization |
|
|
38,076 |
|
|
|
28,949 |
|
|
|
106,158 |
|
|
|
82,959 |
|
EBITDA |
|
|
147,179 |
|
|
|
131,212 |
|
|
|
606,011 |
|
|
|
445,107 |
|
Non-cash stock-based compensation expense |
|
|
24,156 |
|
|
|
33,198 |
|
|
|
(45,514 |
) |
|
|
96,383 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
1,222 |
|
|
|
— |
|
|
|
1,222 |
|
Adjusted EBITDA |
|
$ |
171,335 |
|
|
$ |
165,632 |
|
|
$ |
560,497 |
|
|
$ |
542,712 |
|
Net income margin |
|
|
16.2 |
% |
|
|
18.5 |
% |
|
|
28.0 |
% |
|
|
20.6 |
% |
Adjusted EBITDA margin |
|
|
37.9 |
% |
|
|
40.8 |
% |
|
|
40.3 |
% |
|
|
43.1 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Net income to non-GAAP net income: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
73,278 |
|
|
$ |
75,219 |
|
|
$ |
388,435 |
|
|
$ |
259,031 |
|
Non-cash stock-based compensation expense |
|
|
24,156 |
|
|
|
33,198 |
|
|
|
(45,514 |
) |
|
|
96,383 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
1,222 |
|
|
|
— |
|
|
|
1,222 |
|
Income tax effect on non-GAAP adjustments |
|
|
(4,016 |
) |
|
|
(7,263 |
) |
|
|
(11,020 |
) |
|
|
(17,347 |
) |
Non-GAAP net income |
|
$ |
93,418 |
|
|
$ |
102,376 |
|
|
$ |
331,901 |
|
|
$ |
339,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
55,929 |
|
|
|
57,825 |
|
|
|
56,307 |
|
|
|
57,871 |
|
Diluted |
|
|
55,964 |
|
|
|
57,966 |
|
|
|
56,365 |
|
|
|
58,056 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings per share, basic |
|
$ |
1.31 |
|
|
$ |
1.30 |
|
|
$ |
6.90 |
|
|
$ |
4.48 |
|
Earnings per share, diluted |
|
$ |
1.31 |
|
|
$ |
1.30 |
|
|
$ |
6.89 |
|
|
$ |
4.46 |
|
Non-GAAP net income per share, basic |
|
$ |
1.67 |
|
|
$ |
1.77 |
|
|
$ |
5.89 |
|
|
$ |
5.86 |
|
Non-GAAP net income per share, diluted |
|
$ |
1.67 |
|
|
$ |
1.77 |
|
|
$ |
5.89 |
|
|
$ |
5.84 |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Earnings per share to non-GAAP net income per share, basic: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings per share, basic |
|
$ |
1.31 |
|
|
$ |
1.30 |
|
|
$ |
6.90 |
|
|
$ |
4.48 |
|
Non-cash stock-based compensation expense |
|
|
0.43 |
|
|
|
0.57 |
|
|
|
(0.81 |
) |
|
|
1.67 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
|
0.02 |
|
Income tax effect on non-GAAP adjustments |
|
|
(0.07 |
) |
|
|
(0.12 |
) |
|
|
(0.20 |
) |
|
|
(0.31 |
) |
Non-GAAP net income per share, basic |
|
$ |
1.67 |
|
|
$ |
1.77 |
|
|
$ |
5.89 |
|
|
$ |
5.86 |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Earnings per share to non-GAAP net income per share, diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings per share, diluted |
|
$ |
1.31 |
|
|
$ |
1.30 |
|
|
$ |
6.89 |
|
|
$ |
4.46 |
|
Non-cash stock-based compensation expense |
|
|
0.43 |
|
|
|
0.57 |
|
|
|
(0.81 |
) |
|
|
1.66 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
|
0.02 |
|
Income tax effect on non-GAAP adjustments |
|
|
(0.07 |
) |
|
|
(0.12 |
) |
|
|
(0.19 |
) |
|
|
(0.30 |
) |
Non-GAAP net income per share, diluted |
|
$ |
1.67 |
|
|
$ |
1.77 |
|
|
$ |
5.89 |
|
|
$ |
5.84 |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Adjusted gross profit: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total revenues |
|
$ |
451,934 |
|
|
$ |
406,303 |
|
|
$ |
1,389,327 |
|
|
$ |
1,259,079 |
|
Less: Total cost of revenues |
|
|
(88,353 |
) |
|
|
(68,941 |
) |
|
|
(250,868 |
) |
|
|
(201,601 |
) |
Total gross profit |
|
|
363,581 |
|
|
|
337,362 |
|
|
|
1,138,459 |
|
|
|
1,057,478 |
|
Plus: Non-cash stock-based compensation expense |
|
|
3,873 |
|
|
|
2,868 |
|
|
|
11,027 |
|
|
|
8,606 |
|
Total adjusted gross profit |
|
$ |
367,454 |
|
|
$ |
340,230 |
|
|
$ |
1,149,486 |
|
|
$ |
1,066,084 |
|
Gross margin |
|
|
80.5 |
% |
|
|
83.0 |
% |
|
|
81.9 |
% |
|
|
84.0 |
% |
Adjusted gross margin |
|
|
81.3 |
% |
|
|
83.7 |
% |
|
|
82.7 |
% |
|
|
84.7 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Adjusted sales and marketing expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Sales and marketing expenses |
|
$ |
104,477 |
|
|
$ |
101,162 |
|
|
$ |
326,865 |
|
|
$ |
311,171 |
|
Less: Non-cash stock-based compensation expense |
|
|
(3,303 |
) |
|
|
(6,851 |
) |
|
|
(13,599 |
) |
|
|
(18,367 |
) |
Adjusted sales and marketing expenses |
|
$ |
101,174 |
|
|
$ |
94,311 |
|
|
$ |
313,266 |
|
|
$ |
292,804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total revenues |
|
$ |
451,934 |
|
|
$ |
406,303 |
|
|
$ |
1,389,327 |
|
|
$ |
1,259,079 |
|
Sales and marketing expenses as a % of revenues |
|
|
23.1 |
% |
|
|
24.9 |
% |
|
|
23.5 |
% |
|
|
24.7 |
% |
Adjusted sales and marketing expenses as a % of revenues |
|
|
22.4 |
% |
|
|
23.2 |
% |
|
|
22.5 |
% |
|
|
23.3 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Adjusted total administrative expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total administrative expenses |
|
$ |
258,707 |
|
|
$ |
240,461 |
|
|
$ |
652,631 |
|
|
$ |
712,879 |
|
Less: Non-cash stock-based compensation expense |
|
|
(20,283 |
) |
|
|
(30,330 |
) |
|
|
56,541 |
|
|
|
(87,777 |
) |
Adjusted total administrative expenses |
|
$ |
238,424 |
|
|
$ |
210,131 |
|
|
$ |
709,172 |
|
|
$ |
625,102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total revenues |
|
$ |
451,934 |
|
|
$ |
406,303 |
|
|
$ |
1,389,327 |
|
|
$ |
1,259,079 |
|
Total administrative expenses as a % of revenues |
|
|
57.2 |
% |
|
|
59.2 |
% |
|
|
47.0 |
% |
|
|
56.6 |
% |
Adjusted total administrative expenses as a % of revenues |
|
|
52.8 |
% |
|
|
51.7 |
% |
|
|
51.0 |
% |
|
|
49.6 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Adjusted research and development expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Research and development expenses |
|
$ |
63,047 |
|
|
$ |
51,864 |
|
|
$ |
175,927 |
|
|
$ |
143,651 |
|
Less: Non-cash stock-based compensation expense |
|
|
(7,571 |
) |
|
|
(5,617 |
) |
|
|
(20,716 |
) |
|
|
(17,514 |
) |
Adjusted research and development expenses |
|
$ |
55,476 |
|
|
$ |
46,247 |
|
|
$ |
155,211 |
|
|
$ |
126,137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total revenues |
|
$ |
451,934 |
|
|
$ |
406,303 |
|
|
$ |
1,389,327 |
|
|
$ |
1,259,079 |
|
Research and development expenses as a % of revenues |
|
|
14.0 |
% |
|
|
12.8 |
% |
|
|
12.7 |
% |
|
|
11.4 |
% |
Adjusted research and development expenses as a % of revenues |
|
|
12.3 |
% |
|
|
11.4 |
% |
|
|
11.2 |
% |
|
|
10.0 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Total research and development costs: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Capitalized research and development costs |
|
$ |
33,362 |
|
|
$ |
26,578 |
|
|
$ |
94,394 |
|
|
$ |
70,809 |
|
Research and development expenses |
|
|
63,047 |
|
|
|
51,864 |
|
|
|
175,927 |
|
|
|
143,651 |
|
Total research and development costs |
|
$ |
96,409 |
|
|
$ |
78,442 |
|
|
$ |
270,321 |
|
|
$ |
214,460 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total revenues |
|
$ |
451,934 |
|
|
$ |
406,303 |
|
|
$ |
1,389,327 |
|
|
$ |
1,259,079 |
|
Total research and development costs as a % of revenues |
|
|
21.3 |
% |
|
|
19.3 |
% |
|
|
19.5 |
% |
|
|
17.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted total research and development costs: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total research and development costs |
|
$ |
96,409 |
|
|
$ |
78,442 |
|
|
$ |
270,321 |
|
|
$ |
214,460 |
|
Less: Capitalized non-cash stock-based compensation |
|
|
(5,053 |
) |
|
|
(3,777 |
) |
|
|
(13,850 |
) |
|
|
(11,529 |
) |
Less: Non-cash stock-based compensation expense |
|
|
(7,571 |
) |
|
|
(5,617 |
) |
|
|
(20,716 |
) |
|
|
(17,514 |
) |
Adjusted total research and development costs |
|
$ |
83,785 |
|
|
$ |
69,048 |
|
|
$ |
235,755 |
|
|
$ |
185,417 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total revenues |
|
$ |
451,934 |
|
|
$ |
406,303 |
|
|
$ |
1,389,327 |
|
|
$ |
1,259,079 |
|
Adjusted total research and development costs as a % of revenues |
|
|
18.5 |
% |
|
|
17.0 |
% |
|
|
17.0 |
% |
|
|
14.7 |
% |
Unaudited Components of Non-Cash Stock-Based Compensation Expense (in thousands)
|
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Non-cash stock-based compensation expense: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Operating expenses |
|
$ |
3,873 |
|
|
$ |
2,868 |
|
|
$ |
11,027 |
|
|
$ |
8,606 |
|
Sales and marketing |
|
|
3,303 |
|
|
|
6,851 |
|
|
|
13,599 |
|
|
|
18,367 |
|
Research and development |
|
|
7,571 |
|
|
|
5,617 |
|
|
|
20,716 |
|
|
|
17,514 |
|
General and administrative |
|
|
9,409 |
|
|
|
17,862 |
|
|
|
(90,856 |
) |
|
|
51,896 |
|
Total non-cash stock-based compensation expense |
|
$ |
24,156 |
|
|
$ |
33,198 |
|
|
$ |
(45,514 |
) |
|
$ |
96,383 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030180997/en/
Investor Relations Contact:
investors@paycom.com
Source: